Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$82.2M |
| 2 |
Conagra Brands
CAG
|
+$63.5M |
| 3 |
Intuit
INTU
|
+$53.2M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$51.9M |
| 5 |
CVS Health
CVS
|
+$43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$40.5M |
| 2 |
Merck
MRK
|
+$39.5M |
| 3 |
DD
Du Pont De Nemours E I
DD
|
+$38.8M |
| 4 |
Viatris
VTRS
|
+$38.8M |
| 5 |
DaVita
DVA
|
+$37.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.31% |
| 2 | Industrials | 19.34% |
| 3 | Healthcare | 18.39% |
| 4 | Consumer Discretionary | 16.87% |
| 5 | Consumer Staples | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSTO
251
DELISTED
Vista Outdoor Inc.
VSTO
| $11.2M | 0.13% |
+233,642
| New | +$11.3M |
|
252
Myriad Genetics
MYGN
$306M
| $11M | 0.13% |
360,830
+159,303
| +79% | +$5.53M |
|
253
Oceaneering
OII
$5.28B
| $11M | 0.13% |
367,950
-465,123
| -56% | -$15.2M |
|
|
S
254
DELISTED
Sprint Corporation
S
| $10.9M | 0.13% |
2,414,811
+1,856,359
| +332% | +$6.87M |
|
255
Graham Holdings Company
GHC
$4.94B
| $10.9M | 0.13% |
22,195
-16,028
| -42% | -$7.81M |
|
256
Harley-Davidson
HOG
$2.93B
| $10.8M | 0.13% |
+239,041
| New | +$11M |
|
|
CSGS
257
DELISTED
CSG Systems International
CSGS
| $10.8M | 0.13% |
266,855
-82,170
| -24% | -$3.53M |
|
|
HDS
258
DELISTED
HD Supply Holdings, Inc.
HDS
| $10.7M | 0.13% |
308,104
-251,260
| -45% | -$8.56M |
|
259
F5
FFIV
$21.8B
| $10.7M | 0.13% |
93,597
+16,783
| +22% | +$1.8M |
|
260
MaxLinear
MXL
$6.04B
| $10.6M | 0.13% |
592,048
+525,599
| +791% | +$9.75M |
|
261
Anika Therapeutics
ANIK
$291M
| $10.6M | 0.13% |
198,303
+35,195
| +22% | +$1.66M |
|
|
TIVO
262
DELISTED
TIVO INC
TIVO
| $10.6M | 0.13% |
1,074,255
-48,770
| -4% | -$471K |
|
|
NTUS
263
DELISTED
Natus Medical Inc
NTUS
| $10.6M | 0.13% |
280,046
+195,483
| +231% | +$6.55M |
|
|
IMS
264
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $10.6M | 0.13% |
417,102
+389,674
| +1,421% | +$9.99M |
|
265
Chemours
CC
$2.4B
| $10.5M | 0.13% |
1,279,649
+788,668
| +161% | +$7.03M |
|
|
PRMW
266
DELISTED
Primo Water Corporation
PRMW
| $10.5M | 0.13% |
754,362
-192,524
| -20% | -$2.77M |
|
267
Regeneron Pharmaceuticals
REGN
$85.9B
| $10.5M | 0.13% |
30,151
+27,626
| +1,094% | +$10.6M |
|
268
JB Hunt Transport Services
JBHT
$25.9B
| $10.5M | 0.13% |
+129,977
| New | +$10.7M |
|
269
DNOW Inc
DNOW
$2.83B
| $10.5M | 0.13% |
577,844
+222,130
| +62% | +$3.9M |
|
|
JWN
270
DELISTED
Nordstrom
JWN
| $10.5M | 0.13% |
274,773
-178,837
| -39% | -$7.94M |
|
271
Yum! Brands
YUM
$41.8B
| $10.4M | 0.12% |
174,518
+156,851
| +888% | +$9.24M |
|
272
NVR
NVR
$16.9B
| $10.4M | 0.12% |
5,832
+2,215
| +61% | +$3.79M |
|
273
Ralph Lauren
RL
$22.2B
| $10.3M | 0.12% |
115,330
-40,030
| -26% | -$3.72M |
|
274
Huron Consulting
HURN
$2.57B
| $10.3M | 0.12% |
170,281
+14,793
| +10% | +$860K |
|
275
Robert Half
RHI
$4.58B
| $10.2M | 0.12% |
268,284
-114,237
| -30% | -$4.67M |
|
Similar funds
Joel Greenblatt's Q2 2016 Portfolio in Review
As of Q2 2016, Joel Greenblatt held 1,194 positions worth $8.34B, down 6.5% from $8.92B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Joel Greenblatt withdrew a net $527M in Q2 2016, closing 260 positions and reducing 357 holdings. Its most notable exit was Viatris, an estimated $38.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Twenty-First Century Fox, Inc. Class A worth $76.3M.
- Joel Greenblatt's largest Q2 2016 buy was Twenty-First Century Fox, Inc. Class A: 2,822,168 shares worth $76.3M.
- Joel Greenblatt added most to Paramount Global Class B in Q2 2016, an estimated $51.9M increase.
- Joel Greenblatt's biggest Q2 2016 reduction was Texas Instruments, cutting an estimated $40.5M.
- Joel Greenblatt fully exited Viatris in Q2 2016, selling an estimated $38.8M.
- Joel Greenblatt's ten largest holdings make up 9% of its $8.34B portfolio in Q2 2016.
- Joel Greenblatt opened 244 new positions and closed 260 in Q2 2016.
- Joel Greenblatt's portfolio value fell 6.5% quarter-over-quarter to $8.34B.
Based on Gotham Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.